Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2024-12-19 |
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="236974"/>
<meta>
<versionId value="61"/>
<lastUpdated value="2024-12-14T08:46:28.847Z"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 236974</b></p><a name="236974"> </a><a name="hc236974"> </a><a name="236974-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 61; Last updated: 2024-12-14 08:46:28+0000</p></div><p><b>url</b>: <a href="EvidenceVariable-236974.html">EvidenceVariable OutcomeDefinition: Serious hyperglycaemia</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/236974, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313963, outcomeId/313963, picoId/85798, sectionId/73215, <a href="http://terminology.hl7.org/6.1.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt
This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid:
Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.
This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.24.35</p><p><b>version</b>: 2.0.0-ballot</p><p><b>name</b>: Serious_hyperglycaemia313963</p><p><b>title</b>: OutcomeDefinition: Serious hyperglycaemia</p><p><b>shortTitle</b>: Serious hyperglycaemia</p><p><b>status</b>: Active</p><p><b>date</b>: 2024-12-19 14:29:51+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: </p><div><p>Serious hyperglycaemia</p>
</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style="display: none">*</td><td>Part Of</td><td>MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</td></tr></table><p><b>handling</b>: dichotomous variable</p></div>
</text>
<url value="https://fevir.net/resources/EvidenceVariable/236974"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="urn:ietf:rfc:3986"/>
<value value="https://fevir.net/FOI/236974"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-313963"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<type>
<text value="outcomeId"/>
</type>
<system value="https://app.magicapp.org/#/guidelines"/>
<value value="313963"/>
</identifier>
<identifier>
<type>
<text value="picoId"/>
</type>
<system value="https://app.magicapp.org/#/guidelines"/>
<value value="85798"/>
</identifier>
<identifier>
<type>
<text value="sectionId"/>
</type>
<system value="https://app.magicapp.org/#/guidelines"/>
<value value="73215"/>
</identifier>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.44.24.35"/>
</identifier>
<version value="2.0.0-ballot"/>
<name value="Serious_hyperglycaemia313963"/>
<title value="OutcomeDefinition: Serious hyperglycaemia"/>
<shortTitle value="Serious hyperglycaemia"/>
<status value="active"/>
<date value="2024-12-19T14:29:51+00:00"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description value="Serious hyperglycaemia"/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Computable Publishing®: MAGIC-to-FEvIR Converter"/>
</author>
<relatedArtifact>
<type value="part-of"/>
<resourceReference>
<type value="Composition"/>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-conversion-report"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<display
value="MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"/>
</resourceReference>
</relatedArtifact>
<handling value="dichotomous"/>
</EvidenceVariable>